Christopher Schriever

Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin

Stuart Johnson, Christopher Schriever, Minerva Galang et al. · Clinical Infectious Diseases · 2007 · 309 citations

Vancomycin Therapy, Antimicrobial Susceptibility, Health Sciences +12

Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment

Stuart Johnson, Christopher Schriever, Ursula Patel et al. · Anaerobe · 2009 · 121 citations

Antimicrobial Susceptibility, Antibiotics, Antimicrobial Stewardship +8

Long-term montelukast therapy in moderate to severe COPD—a preliminary observation

Israel Rubinstein, Brijesh Kumar, Christopher Schriever · Respiratory Medicine · 2003 · 46 citations · Full text

Advanced Lung Disease, Pulmonary Medicine, Long-term Montelukast Therapy +2

Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin at 750 Milligrams and Various Doses of Metronidazole in Healthy Adult Subjects

Kelly A. Sprandel, Christopher Schriever, Susan L. Pendland et al. · Antimicrobial Agents and Chemotherapy · 2004 · 34 citations · Full text

Various Doses, Escherichia Coli, Healthy Adult Subjects +16

Sex‐Related Differences in the Pharmacokinetics of Once‐Daily Saquinavir Soft‐Gelatin Capsules Boosted with Low‐Dose Ritonavir in Patients Infected with Human Immunodeficiency Virus Type 1

Manjunath P. Pai, Christopher Schriever, Mariela Diaz‐Linares et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2004 · 33 citations